CRI Related Analyst Comments
-
Goldman Sachs Starts Ascena Retail Group (ASNA) at Neutral
-
Goldman Sachs Starts Carter's (CRI) at Neutral
-
Jefferies Raises Estimates and Price Target on Caliper Life Sciences (CALP), Maintains Buy Rating
-
Sterne Agee Adds Carter's (CRI) to 'Featured Selections' List, Removes BB&T (BBT), Christopher & Banks (CBK)
-
Goldman Sachs Suspended Coverage on Carter's (CRI) After Earnings Delay
-
WR Hambrecht Maintains Positive Stance on Carters (CRI)
Back to CRI Stock Lookup
